1.Progress of research on cholangiocyte proliferation and apoptosis.
Chong-hui LI ; Ming-yi CHEN ; Zhi-qiang HUANG
Chinese Journal of Hepatology 2005;13(5):399-400
Animals
;
Apoptosis
;
physiology
;
Bile Duct Diseases
;
pathology
;
Bile Ducts
;
cytology
;
pathology
;
Cell Proliferation
;
Epithelial Cells
;
metabolism
;
pathology
;
Humans
2.Epithelial-Mesenchymal Transitions of Bile Duct Epithelial Cells in Primary Hepatolithiasis.
Lijin ZHAO ; Rigao YANG ; Long CHENG ; Maijian WANG ; Yan JIANG ; Shuguang WANG
Journal of Korean Medical Science 2010;25(7):1066-1070
The purpose of this study was to explore the role of epithelial-mesenchymal transition in the pathogenesis of hepatolithiasis. Thirty-one patients with primary hepatolithiasis were enrolled in this study. Expressions of E-cadherin, alpha-catenin, alpha-SMA, vimentin, S100A4, TGF-beta1 and P-smad2/3 in hepatolithiasis bile duct epithelial cells were examined by immunohistochemistry staining. The results showed that the expressions of the epithelial markers E-cadherin and alpha-catenin were frequently lost in hepatolithiasis (32.3% and 25.9% of cases, respectively), while the mesenchymal markers vimentin, alpha-SMA and S100A4 were found to be present in hepatolithiasis (35.5%, 29.0%, and 32.3% of cases, respectively). The increased mesenchymal marker expression was correlated with decreased epithelial marker expression. The expressions of TGF-beta1 and P-smad2/3 in hepatolithiasis were correlated with the expression of S100A4. These data indicate that TGF-beta1-mediated epithelial-mesenchymal transition might be involved in the formation of hepatolithiasis.
Adult
;
*Bile Ducts/cytology/metabolism/pathology
;
Biological Markers/*metabolism
;
Cell Differentiation/*physiology
;
Epithelial Cells/cytology/*physiology
;
Epithelium/physiology
;
Female
;
*Gallstones/metabolism/pathology
;
Humans
;
Liver Diseases/metabolism/*pathology
;
Male
;
Mesoderm/cytology/*physiology
;
Middle Aged
3.Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation.
Ji Hye JUN ; Jong Ho CHOI ; Si Hyun BAE ; Seh Hoon OH ; Gi Jin KIM
Clinical and Molecular Hepatology 2016;22(3):372-381
BACKGROUND/AIMS: Chronic liver disease leads to liver fibrosis, and although the liver does have a certain regenerative capacity, this disease is associated with dysfunction of the liver vessels. C-reactive protein (CRP) is produced in the liver and circulated from there for metabolism. CRP was recently shown to inhibit angiogenesis by inducing endothelial cell dysfunction. The objective of this study was to determine the effect of CRP levels on angiogenesis in a rat model of liver dysfunction induced by bile duct ligation (BDL). METHODS: The diameter of the hepatic vein was analyzed in rat liver tissues using hematoxylin and eosin (H&E) staining. The expression levels of angiogenic factors, albumin, and CRP were analyzed by real-time PCR and Western blotting. A tube formation assay was performed to confirm the effect of CRP on angiogenesis in human umbilical vein endothelial cells (HUVECs) treated with lithocholic acid (LCA) and siRNA-CRP. RESULTS: The diameter of the hepatic portal vein increased significantly with the progression of cirrhosis. The expression levels of angiogenic factors were increased in the cirrhotic liver. In contrast, the expression levels of albumin and CRP were significantly lower in the liver tissue obtained from the BDL rat model than in the normal liver. The CRP level was correlated with the expression of albumin in hepatocytes treated with LCA and siRNA-CRP. Tube formation was significantly decreased in HUVECs when they were treated with LCA or a combination of LCA and siRNA-CRP. CONCLUSION: CRP seems to be involved in the abnormal formation of vessels in hepatic disease, and so it could be a useful diagnostic marker for hepatic disease.
Angiogenic Proteins/genetics/metabolism
;
Animals
;
Bile Ducts/surgery
;
C-Reactive Protein/*analysis/genetics/metabolism
;
Cells, Cultured
;
Disease Models, Animal
;
Hepatic Veins/abnormalities
;
Hepatocytes/cytology/metabolism
;
Human Umbilical Vein Endothelial Cells
;
Humans
;
Lithocholic Acid/pharmacology
;
Liver/metabolism/pathology
;
Liver Cirrhosis/etiology
;
Liver Diseases/metabolism/*pathology
;
Male
;
Microscopy, Fluorescence
;
Mitochondria/drug effects/metabolism
;
RNA Interference
;
RNA, Small Interfering/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Real-Time Polymerase Chain Reaction
;
Serum Albumin/genetics/metabolism